Inari Medical Inc. (NARI)
NASDAQ: NARI
· Real-Time Price · USD
79.97
0.00 (0.00%)
At close: Feb 18, 2025, 3:59 PM
Inari Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 574.5M | 547.47M | 520.66M | 493.63M | 469.31M | 439.15M | 412.89M | 383.47M | 358.92M | 335.63M | 306.34M | 276.98M | 242.38M | 208.18M | 170.11M |
Cost of Revenue | 80.42M | 75.05M | 65.35M | 60.2M | 55.19M | 51.78M | 48.28M | 44.51M | 39.66M | 35.63M | 30.1M | 24.76M | 20.16M | 16.35M | 15.02M |
Gross Profit | 494.08M | 472.42M | 455.31M | 433.43M | 414.12M | 387.37M | 364.61M | 338.96M | 319.26M | 300M | 276.24M | 252.23M | 222.21M | 191.82M | 155.09M |
Operating Income | -48.02M | -32.34M | -18.17M | -2.15M | -6.44M | -18.35M | -26.17M | -28.1M | -20.46M | -13.39M | 49K | 10.84M | 16.09M | 26.01M | 21.3M |
Interest Income | 6.08M | 9.18M | 12.66M | 15.61M | 13.87M | 10.29M | 5.95M | 1.85M | 906K | 315K | 136K | 154K | 205K | 386K | 497K |
Pretax Income | -53.36M | -35.09M | -10.65M | 4.24M | 2.61M | -12.29M | -24.25M | -26.18M | -19.7M | -13.13M | -111K | 10.69M | 15.99M | 25.23M | 17.34M |
Net Income | -78.58M | -57.05M | -23.62M | -1.64M | -2.77M | -16.08M | -28.36M | -29.31M | -22.41M | -15.06M | -805K | 9.84M | 15.72M | 25.02M | 17.15M |
Selling & General & Admin | 417.04M | 397.05M | 369.59M | 352.23M | 339.69M | 327.24M | 314.81M | 292.84M | 267.19M | 247.46M | 217.2M | 190.37M | 167.29M | 134.27M | 110.25M |
Research & Development | 104.11M | 96.17M | 92.35M | 87.53M | 85.05M | 82.67M | 80.15M | 74.22M | 72.53M | 65.93M | 58.99M | 51.02M | 38.83M | 31.55M | 23.54M |
Other Expenses | 9.41M | -682K | -679K | -617K | -430K | 193K | 419K | 356K | 155K | 244K | -1K | -18K | -15K | -45K | -52K |
Operating Expenses | 533.02M | 495.68M | 464.4M | 439.76M | 424.75M | 409.91M | 394.96M | 367.06M | 339.72M | 313.39M | 276.19M | 241.38M | 206.12M | 165.81M | 133.79M |
Interest Expense | 302K | 267K | 234K | 196K | 201K | 232K | 261K | 294K | 295K | 294K | 295K | 295K | 295K | 473K | 862K |
Selling & Marketing Expenses | 1.2M | 1.2M | 1.2M | 1.2M | 957K | 957K | 957K | 957K | 344K | 344K | 344K | 344K | n/a | 106K | 106K |
Cost & Expenses | 613.44M | 570.74M | 529.75M | 499.97M | 479.94M | 461.68M | 443.24M | 411.57M | 379.38M | 349.02M | 306.29M | 266.14M | 226.28M | 182.16M | 148.82M |
Income Tax Expense | 25.23M | 21.96M | 12.97M | 5.88M | 5.38M | 3.79M | 4.11M | 3.13M | 2.71M | 1.93M | 694K | 845K | 271K | 210K | 198K |
Shares Outstanding (Basic) | 58.37M | 58.14M | 57.94M | 57.64M | 57.38M | 57.21M | 54.76M | 53.61M | 53.44M | 53.18M | 50.95M | 50.23M | 50M | 49.67M | 49.36M |
Shares Outstanding (Diluted) | 58.37M | 58.14M | 57.94M | 57.64M | 58.59M | 58.5M | 54.76M | 53.61M | 53.49M | 53.18M | 50.95M | 55.63M | 50M | 55.6M | 55.72M |
EPS (Basic) | -1.35 | -0.98 | -0.4 | -0.02 | -0.05 | -0.3 | -0.53 | -0.55 | -0.42 | -0.29 | -0.02 | 0.19 | 0.31 | 0.50 | 0.26 |
EPS (Diluted) | -1.35 | -0.99 | -0.41 | -0.03 | -0.06 | -0.3 | -0.53 | -0.55 | -0.42 | -0.29 | -0.03 | 0.16 | 0.27 | 0.45 | 0.22 |
EBITDA | -36.16M | -21.14M | 673K | 13.88M | 11.99M | -3.31M | -15.56M | -18.77M | -12.46M | -6.57M | 5.55M | 15.51M | 19.49M | 28.64M | 20.54M |
EBIT | -53.05M | -38.35M | -13.93M | 922K | -707K | -12.06M | -23.99M | -25.89M | -19.4M | -12.83M | 142K | 10.91M | 16.21M | 25.63M | 18.18M |
Depreciation & Amortization | 16.9M | 13.69M | 11.09M | 9.45M | 9.18M | 8.75M | 8.43M | 7.12M | 6.94M | 6.26M | 5.37M | 4.53M | 3.27M | 2.56M | 1.94M |